Company Description
For FY2025, Bodhi Tree Biotechnology reported revenue of $17K with net income of -$150K and diluted earnings per share of -$0.01. The company operates at a net profit margin of -880.4%.
This page collects what Stock Titan holds for BDTB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bodhi Tree Biotechnology (BDTB) last closed at $0.2000.
BDTB Rankings
Latest News
SEC Filings
Bodhi Tree Biotechnology has filed 4 recent SEC filings, including 3 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BDTB SEC filings →
Financial Highlights
Bodhi Tree Biotechnology generated $17K in revenue in FY2025, operating income reached -$148K (-868.3% operating margin), and net income was -$150K, reflecting a -880.4% net profit margin. Diluted earnings per share stood at -$0.01. The company generated -$150K in operating cash flow.